Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marcucci

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Developmental Neurobiology|June 5, 2024
A C-terminal motif containing a PKC phosphorylation site regulates γ-Protocadherin-mediated dendrite arborization in the cerebral cortex in vivoCamille M Hanes, Kar Men Mah, David M Steffen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2019
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivorsG Marcucci, G Beltrami, A Tamburini, et al.
Leukemia|May 11, 2013
Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AMLK M Bernot, R F Siebenaler, S P Whitman, et al.
Leukemia|December 10, 2014
miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with IbrutinibD Guinn, A S Ruppert, K Maddocks, et al.
Oncogene|May 26, 1999
Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 geneC Plass, F Yu, L Yu, et al.
Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.
Cancer Research|February 24, 2001
The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemiaS P Whitman, M P Strout, G Marcucci, et al.
Leukemia|May 15, 2013
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic targetJ G Harb, P Neviani, B J Chyla, et al.
Calcified Tissue International|April 23, 2015
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro MineralizationL Masi, G Beltrami, S Ottanelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?G Marcucci, E Biver, J J Body, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Developmental Neurobiology|June 5, 2024
A C-terminal motif containing a PKC phosphorylation site regulates γ-Protocadherin-mediated dendrite arborization in the cerebral cortex in vivoCamille M Hanes, Kar Men Mah, David M Steffen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2019
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivorsG Marcucci, G Beltrami, A Tamburini, et al.
Leukemia|May 11, 2013
Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AMLK M Bernot, R F Siebenaler, S P Whitman, et al.
Leukemia|December 10, 2014
miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with IbrutinibD Guinn, A S Ruppert, K Maddocks, et al.
Oncogene|May 26, 1999
Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 geneC Plass, F Yu, L Yu, et al.
Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.
Cancer Research|February 24, 2001
The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemiaS P Whitman, M P Strout, G Marcucci, et al.
Leukemia|May 15, 2013
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic targetJ G Harb, P Neviani, B J Chyla, et al.
Calcified Tissue International|April 23, 2015
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro MineralizationL Masi, G Beltrami, S Ottanelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?G Marcucci, E Biver, J J Body, et al.
Pageof 11